| ST003287 Metabolic profiling and synergistic therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| beta-Alanine Metabolism (1) | SMP0000007 | map00410 |
| Pyrimidine Metabolism (1) | SMP0000046 | map00240 |
